Research Article
Fibrinogen and Albumin Score Changes during Preoperative Treatment Can Predict Prognosis in Patients with Locally Advanced Rectal Cancer
Table 1
Patient clinicopathologic characteristics.
| | | Value |
| | Age (years) | Median (range) | 60 (19-83) | | cTNM | II/III | 45/61 | | Pathology | Adenocarcinoma/mucinous | 101/5 | | ypT | 0/1/2/3/4 | 24/5/46/29/2 | | ypN | 0/1/2 | 80/18/8 | | pCR | Yes/no | 23/83 | | ypTNM | 0/I/II/III/IV | 23/40/17/26/0 | | CEA | Median (range) | 3.20 (0.50-172.92) | | CA19-9 | Median (range) | 11.40 (1.20-1022.50) | | Pre-CRT Fib (mg/dl) | Median (range) | 3.45 (0.50-6.84) | | Post-CRT Fib (mg/dl) | Median (range) | 3.37 (1.85-7.67) | | Pre-CRT Alb (g/l) | Median (range) | 40.35 (27.0-50.20) | | Post-CRT Alb (g/l) | Median (range) | 40.40 (23.4-51.90) | | Pre-CRT FA score | 0/1/2 | 85/16/5 | | Post-CRT FA score | 0/1/2 | 75/24/7 |
|
|
pCR: pathologic complete response; CEA: carcinoembryonic antigen; CA19-9: carbohydrate antigen 19-9; CRT: chemoradiotherapy; Fib: fibrinogen; Alb: albumin; FA: fibrinogen and albumin.
|
